Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder

被引:65
作者
Hemmings, SM
Kinnear, CJ
Niehaus, DJH
Moolman-Smook, JC
Lochner, C
Knowles, JA
Corfield, VA
Stein, DJ
机构
[1] Univ Stellenbosch, MRC US, Ctr Mol & Cellular Biol, ZA-7505 Tygerberg, South Africa
[2] Univ Stellenbosch, MRC, Unit Anxiet Disorders, Dept Psychiat,Fac Hlth Sci, ZA-7505 Tygerberg, South Africa
[3] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
obsessive-compulsive disorder; genetics; association studies; Afrikaner;
D O I
10.1016/S0924-977X(02)00129-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is increasing evidence that the aetiology of obsessive-compulsive disorder (OCD) has a marked genetic component, although the precise mechanism of inheritance is unclear. Clinical and pharmacological studies have implicated the serotonergic and dopaminergic systems in disease pathogenesis. This study investigated the role of attractive candidate genes in the serotonergic and dopaminergic pathways in the development of OCD. The distribution of selected polymorphic variants in the serotonin receptor type 2A and 1Dbeta (5-HT2A, 5-HT1Dbeta), dopamine transporter (DAT), dopamine receptor type 4 (DRD4) and monoamine-oxidase A (MAO-A) genes were analysed in 71 OCD cases and 129 control individuals in the genetically homogeneous Afrikaner population, by means of case-control association studies. Although no statistically significant genotypic or allelic associations were detected, the data yielded interesting preliminary results that warrant further discussion and investigation. (C) 2002 Elsevier Science B.V./ECNP All rights reserved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 57 条
[21]   An update on obsessive-compulsive disorder [J].
Jenike, MA .
BULLETIN OF THE MENNINGER CLINIC, 2001, 65 (01) :4-25
[22]   Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder [J].
Karayiorgou, M ;
Sobin, C ;
Blundell, ML ;
Galke, BL ;
Malinova, L ;
Goldberg, P ;
Ott, J ;
Gogos, JA .
BIOLOGICAL PSYCHIATRY, 1999, 45 (09) :1178-1189
[23]   Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder [J].
Karayiorgou, M ;
Altemus, M ;
Galke, BL ;
Goldman, D ;
Murphy, DL ;
Ott, J ;
Gogos, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4572-4575
[24]   Sumatriptan, 5-MT1D receptors and obsessive-compulsive disorder [J].
Koran, LM ;
Pallanti, S ;
Quercioli, L .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (02) :169-172
[25]  
LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121
[26]   A HYPERVARIABLE SEGMENT IN THE HUMAN DOPAMINE RECEPTOR D(4) (DRD4) GENE [J].
LICHTER, JB ;
BARR, CL ;
KENNEDY, JL ;
VANTOL, HHM ;
KIDD, KK ;
LIVAK, KJ .
HUMAN MOLECULAR GENETICS, 1993, 2 (06) :767-773
[27]  
Liebowitz M R, 1990, Acta Psychiatr Scand Suppl, V360, P29
[28]   A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder [J].
McDougle, CJ ;
Epperson, CN ;
Pelton, GH ;
Wasylink, S ;
Price, LH .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (08) :794-801
[29]  
MCDOUGLE CJ, 1994, ARCH GEN PSYCHIAT, V51, P302
[30]   The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events [J].
Moolman-Smook, JC ;
De Lange, WJ ;
Bruwer, ECD ;
Brink, PA ;
Corfield, VA .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (05) :1308-1320